Effect of chronic administration of a CRF1 receptor antagonist, CRA1000, on locomotor activity and endocrine responses to stress

European Journal of Pharmacology

Volumn 457, Issue 2-3, 2002, Pages 201-206

  Ohata, Hisayuki ^a   Arai, Keiko ^a   Shibasaki, Tamotsu ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

ACTH (adrenocorticotropic hormone); Corticosterone; CRA1000; CRF receptor; Immobilization stress

Indexed keywords

4 [4 (3 FLUOROPHENYL) 1,2,3,6 TETRAHYDRO 1 PYRIDINYL] 2 [N ETHYL N (4 ISOPROPYL 2 METHYLTHIOPHENYL)AMINO] 6 METHYLPYRIMIDINE; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; RECEPTOR SUBTYPE; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CRF RECEPTOR TYPE 1; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOSTERONE RELEASE; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; DARKNESS; DOSE RESPONSE; DOSE TIME EFFECT RELATION; FEEDING BEHAVIOR; FLUID INTAKE; FOOD INTAKE; HORMONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION STRESS; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; TASK PERFORMANCE; ANIMAL; BLOOD; DRUG ANTAGONISM; DRUG EFFECT; ENDOCRINE GLAND; EXERCISE; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; STRESS; WISTAR RAT;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; BODY WEIGHT; CORTICOSTERONE; ENDOCRINE GLANDS; FEEDING BEHAVIOR; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INJECTIONS, INTRAPERITONEAL; MALE; MOTOR ACTIVITY; PITUITARY-ADRENAL SYSTEM; PYRIDINES; PYRIMIDINES; RATS; RATS, WISTAR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RESTRAINT, PHYSICAL; STRESS;

EID: 0037146881     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02663-8     Document Type: Article

References (31)

1. Arai K., Ohata H., Shibasaki T. Non-peptidic corticotropin-releasing hormone receptor type 1 antagonist reverses restraint stress-induced shortening of sodium pentobarbital-induced sleeping time of rats: evidence that an increase in arousal induced by stress is mediated through CRH receptor type 1. Neurosci. Lett. 255:1998;103-106.
2. Arborelius L., Skelton K.H., Thrivikraman K.V., Plotsky P.M., Schulz D.W., Owens M.J. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat. J. Pharmacol. Exp. Ther. 294:2000;588-597.
3. Bornstein S.R., Webster E.L., Torpy D.J., Richman S.J., Mitsiades N., Igel M., Lewis D.B., Rice K.C., Joost H.G., Tsokos M., Chrousos G.P. Chronic effects of a nonpeptide corticotropin-releasing hormone type 1 receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation. Endocrinology. 139:1998;1546-1555.
4. Bradbury M.J., McBurnie M.I., Denton D.A., Lee K.F., Vale W.W. Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice. Endocrinology. 141:2000;2715-2724.
5. Britton K.T., Lee G., Vale W., Rivier J., Koob G.F. Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat. Brain Res. 369:1986;303-306.
6. 1 receptor mRNA expression. J. Neurosci. 15:1995;6340-6350.
7. Chen R., Lewis K.A., Perrin M.H., Vale W.W. Expression cloning of a human corticotropin-releasing-factor receptor. Proc. Natl. Acad. Sci. (U. S. A.). 90:1993;8967-8971.
8. Contarino A., Dellu F., Koob G.F., Smith G.W., Lee K.F., Vale W.W., Gold L.H. Dissociation of locomotor activation and suppression of food intake induced by CRF in CRFR1-deficient mice. Endocrinology. 141:2000;2698-2702.
9. Coste S.C., Kesterson R.A., Heldwein K.A., Stevens S.L., Heard A.D., Hollis J.H., Murray S.E., Hill J.K., Pantely G.A., Hohimer A.R., Hatton D.C., Phillips T.J., Finn D.A., Low M.J., Rittenberg M.B., Stenzel P., Stenzel-Poore M.P. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat. Genet. 24:2000;403-409.
10. Cullen M.J., Ling N., Foster A.C., Pelleymounter M.A. Urocortin, corticotropin releasing factor-2 receptors and energy balance. Endocrinology. 142:2001;992-999.
11. Deak T., Nguyen K.T., Ehrlich A.L., Watkins L.R., Spencer R.L., Maier S.F., Licinio J., Wong M.-L., Chrousos G.P., Webster E., Gold P.W. The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress. Endocrinology. 140:1999;79-86.
12. Dunn A.J., Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress response? Brain Res. Rev. 15:1990;71-100.
13. Egawa M., Yoshimatsu H., Bray G.A. Effect of corticotropin releasing hormone and neuropeptide Y on electrophysiological activity of sympathetic nerves to interscapular brown adipose tissue. Neuroscience. 34:1990;771-775.
14. Griebel G., Perrault G., Sanger D.J. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone. Psychopharmacology. 138:1998;55-66.
15. Heinrichs S.C., Joppa M. Dissociation of arousal-like from anxiogenic-like actions of brain corticotropin-releasing factor receptor ligands in rats. Behav. Brain Res. 122:2001;43-50.
16. 2, receptors mediate anxiogenic-like behavior. Regul. Pept. 71:1997;15-21.
17. Hotta M., Shibasaki T., Yamauchi N., Ohno H., Benoit R., Ling N., Demura H. The effects of chronic central administration of corticotropin-releasing factor on food intake, body weight, and hypothalamic-pituitary-adrenocortical hormones. Life Sci. 48:1991;1483-1491.
18. Hotta M., Shibasaki T., Arai K., Demura H. Corticotropin-releasing factor receptor type 1 mediates emotional stress-induced inhibition of food intake and behavioral changes in rats. Brain Res. 823:1999;221-225.
19. Krahn D.D., Gosnell B.A., Grace M., Levine A.S. CRF antagonist partially reverses CRF- and stress-induced effects on feeding. Brain Res. Bull. 17:1986;285-289.
20. Liebsch G., Landgraf R., Engelmann M., Lörscher P., Holsboer F. Differential behavioural effects of chronic infusion of CRH1 and CRH2 receptor antisense oligonucleotides into the rat brain. J. Psychiatr. Res. 33:1999;153-163.
21. Lovenberg T.W., Liaw C.W., Grigoriadis D.E., Clevenger W., Chalmers D.T., De Souza E.B., Oltersdorf T. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. (U.S.A.). 92:1995;836-840.
22. Lundkvist J., Chai Z., Teheranian R., Hasanvan H., Bartfai T., Jenck F., Widmer U., Moreau J.L. A non-peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity. Eur. J. Pharmacol. 309:1996;195-200.
23. Menzaghi F., Howard R.L., Heinrichs S.C., Vale W., Rivier L., Koob G.F. Characterization of a novel and potent corticotropin-releasing factor antagonist in rats. J. Pharmacol. Exp. Ther. 269:1994;564-572.
24. Muller M.B., Keck M.E., Zimmermann S., Holsboer F., Wurst W. Disruption of feeding behavior in CRH receptor 1-deficient mice is dependent on glucocorticoids. NeuroReport. 11:2000;1963-1966.
25. Ohata H., Suzuki K., Oki Y., Shibasaki T. Urocortin in the ventromedial hypothalamic nucleus acts as an inhibitor of feeding behavior in rats. Brain Res. 861:2000;1-7.
26. Okuyama S., Chaki S., Kawashima N., Suzuki Y., Ogawa S., Nakazato A., Kumagai T., Okubo T., Tomisawa K. Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001. J. Pharmacol. Exp. Ther. 289:1999;926-935.
27. Pelleymounter M.A., Joppa M., Carmouche M., Cullen J., Brown B., Murphy B., Grigoriadis D.E., Ling N., Foster A.C. Role of corticotropin-releasing factor (CRF) receptors in the anorexic syndrome induced by CRF. J. Pharmacol. Exp. Ther. 293:2000;799-806.
28. Reyes T.M., Lewis K., Perrin M.H., Kunitake K.S., Vaughan J., Arias C.A., Hogenesch J.B., Gulyas J., Rivier J., Vale W.W., Sawchenko P.E. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc. Natl. Acad. Sci. (U. S. A.). 98:2001;2843-2848.
29. 2 receptors in corticotropin-releasing factor- and urocortin-induced anorexia. NeuroReport. 9:1998;1601-1606.
30. Sutton R.E., Koob G.F., Le Moal M., Rivier J., Vale W. Corticotropin releasing factor produces behavioural activation in rats. Nature. 297:1982;331-333.
31. Wong M.L., Webster E.L., Spokes H., Phu P., Ehrhart-Bornstein M., Bornstein S., Park C.S., Rice K.C., Chrousos G.P., Licinio J., Gold P.W. Chronic administration of the non-peptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis responses to acute immobilization stress. Life Sci. 65:1999;PL53-PL58.